查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1980686

全球心臟瓣膜牵开器市场规模、份额、趋势和成长分析报告（2026-2034年）

Global Cardiac Valvulotome Market Size, Share, Trends & Growth Analysis Report 2026-2034
出版日期: | 出版商: Value Market Research | 英文 141 Pages | 商品交期: 最快1-2个工作天内

价格
简介目录

预计心臟瓣膜牵开器市场将从 2025 年的 1.4556 亿美元成长到 2034 年的 2.2368 亿美元，2026 年至 2034 年的复合年增长率为 4.89%。

随着对先进心血管外科手术器械的需求持续旺盛，全球心臟瓣膜牵开器市场正稳定成长。心臟瓣膜牵开器是一种专门用于修復或矫正受损心臟瓣膜的手术器械。心臟病发病率的上升以及对有效手术方式日益增长的需求，都推动了该市场的扩张。

推动市场成长的因素包括心血管疾病发生率上升、人口老化以及外科技术的进步。医院和医疗机构越来越多地采用先进的手术器械，以提高手术精度和改善病患预后。此外，发展中地区医疗保健投资的增加和心臟护理服务可近性的提高也促进了市场发展。

展望未来，心臟瓣膜牵开器市场有望受益于医疗技术和外科手术的不断进步。微创心血管手术日益受到重视以及手术器械的改进将进一步推动市场需求成长。随着医疗系统持续优先发展心血管疾病的先进治疗方法，预计未来几年该市场将保持稳定成长。

目录

第一章：引言

第二章执行摘要

第三章 市场变数、趋势与框架

  • 市场谱系展望
  • 渗透率和成长前景分析
  • 价值链分析
  • 法律规范
    • 标准与合规性
    • 监管影响分析
  • 市场动态
    • 市场驱动因素
    • 市场限制因素
    • 市场机会
    • 市场挑战
  • 波特五力分析
  • PESTLE分析

第四章 全球心臟瓣膜牵开器市场：按类型划分

  • 市场分析、洞察与预测
  • 可扩张心臟瓣膜牵开器
  • 导丝式心臟瓣膜牵开器

第五章：全球心臟瓣膜牵开器市场：依手术类型划分

  • 市场分析、洞察与预测
  • 瓣膜切开术
  • 二尖瓣交界处
  • 其他（例如，三尖瓣狭窄）

第六章 全球心臟瓣膜牵开器市场：依最终使用者划分

  • 市场分析、洞察与预测
  • 医院和诊所
  • 心臟外科中心
  • 门诊手术中心
  • 其他（研究机构等）

第七章 全球心臟瓣膜牵开器市场：依地区划分

  • 区域分析
  • 北美市场分析、洞察与预测
    • 我们
    • 加拿大
    • 墨西哥
  • 欧洲市场分析、洞察与预测
    • 英国
    • 法国
    • 德国
    • 义大利
    • 俄罗斯
    • 其他欧洲国家
  • 亚太市场分析、洞察与预测
    • 印度
    • 日本
    • 韩国
    • 澳洲
    • 东南亚
    • 其他亚太国家
  • 拉丁美洲市场分析、洞察与预测
    • 巴西
    • 阿根廷
    • 秘鲁
    • 智利
    • 其他拉丁美洲国家
  • 中东和非洲市场分析、洞察与预测
    • 沙乌地阿拉伯
    • UAE
    • 以色列
    • 南非
    • 其他中东和非洲国家

第八章 竞争情势

  • 最新趋势
  • 公司分类
  • 供应链和销售管道合作伙伴（根据现有资讯）
  • 市场占有率和市场定位分析（基于现有资讯）
  • 供应商情况（基于现有资讯）
  • 策略规划

第九章：公司简介

  • 主要公司的市占率分析
  • 公司简介
    • LeMaitre Vascular Inc
    • Invamed
    • LimFlow Inc
    • B. Braun Melsungen AG
    • Teleflex Incorporated
    • StarFish Medical
    • Koven Technology Inc
    • Becton
    • Dickinson And Company（BD）
    • Symmetry Surgical Inc
    • Andramed GmbH
    • OxSyBio Ltd
简介目录
Product Code: VMR112114869

The Cardiac Valvulotome Market size is expected to reach USD 223.68 Million in 2034 from USD 145.56 Million (2025) growing at a CAGR of 4.89% during 2026-2034.

The Global Cardiac Valvulotome Market is growing steadily as the demand for advanced cardiovascular surgical tools continues to rise. Cardiac valvulotomes are specialized medical instruments used during heart valve surgeries to repair or modify damaged valves. The increasing prevalence of heart diseases and the growing need for effective surgical procedures are contributing to the expansion of this market.

Several factors are driving market growth, including the rising incidence of cardiovascular disorders, aging populations, and improvements in surgical techniques. Hospitals and healthcare facilities are increasingly adopting advanced surgical instruments that enhance precision and patient outcomes. Additionally, growing healthcare investments and improved access to cardiac care in developing regions are supporting market development.

Looking forward, the cardiac valvulotome market is expected to benefit from ongoing advancements in medical technology and surgical procedures. The increasing focus on minimally invasive cardiac surgeries and improved surgical instruments will further drive demand. As healthcare systems continue to prioritize advanced treatment options for cardiovascular diseases, the market is projected to experience steady growth in the coming years.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Type

  • Expandable Cardiac Valvulotome
  • Over the Wire Cardiac Valvulotome

By Procedure Type

  • Valvulotomy
  • Mitral Valve Commissurotomy
  • Others (Tricuspid Valve Stenosis, etc.)

By End User

  • Hospitals & Clinics
  • Cardiac Surgery Centers
  • Ambulatory Surgical Centers
  • Others (Research Institutes, etc.)

COMPANIES PROFILED

  • LeMaitre Vascular Inc, Invamed, LimFlow Inc, B Braun Melsungen AG, Teleflex Incorporated, StarFish Medical, Koven Technology Inc, Becton, Dickinson and Company BD, Symmetry Surgical Inc, Andramed GmbH, OxSyBio Ltd
  • We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definition
  • 1.3. Information Procurement
    • 1.3.1 Information Analysis
    • 1.3.2 Market Formulation & Data Visualization
    • 1.3.3 Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

  • 2.1. Market Snapshot
  • 2.2. Segmental Outlook
  • 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

  • 3.1. Market Lineage Outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Value Chain Analysis
  • 3.4. Regulatory Framework
    • 3.4.1 Standards & Compliance
    • 3.4.2 Regulatory Impact Analysis
  • 3.5. Market Dynamics
    • 3.5.1 Market Drivers
    • 3.5.2 Market Restraints
    • 3.5.3 Market Opportunities
    • 3.5.4 Market Challenges
  • 3.6. Porter's Five Forces Analysis
  • 3.7. PESTLE Analysis

Chapter 4. GLOBAL CARDIAC VALVULOTOME MARKET: BY TYPE 2022-2034 (USD MN)

  • 4.1. Market Analysis, Insights and Forecast Type
  • 4.2. Expandable Cardiac Valvulotome Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.3. Over the Wire Cardiac Valvulotome Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL CARDIAC VALVULOTOME MARKET: BY PROCEDURE TYPE 2022-2034 (USD MN)

  • 5.1. Market Analysis, Insights and Forecast Procedure Type
  • 5.2. Valvulotomy Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.3. Mitral Valve Commissurotomy Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.4. Others (Tricuspid Valve Stenosis, etc.) Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL CARDIAC VALVULOTOME MARKET: BY END USER 2022-2034 (USD MN)

  • 6.1. Market Analysis, Insights and Forecast End User
  • 6.2. Hospitals & Clinics Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.3. Cardiac Surgery Centers Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.4. Ambulatory Surgical Centers Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.5. Others (Research Institutes, etc.) Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL CARDIAC VALVULOTOME MARKET: BY REGION 2022-2034(USD MN)

  • 7.1. Regional Outlook
  • 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.2.1 By Type
    • 7.2.2 By Procedure Type
    • 7.2.3 By End User
    • 7.2.4 United States
    • 7.2.5 Canada
    • 7.2.6 Mexico
  • 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.3.1 By Type
    • 7.3.2 By Procedure Type
    • 7.3.3 By End User
    • 7.3.4 United Kingdom
    • 7.3.5 France
    • 7.3.6 Germany
    • 7.3.7 Italy
    • 7.3.8 Russia
    • 7.3.9 Rest Of Europe
  • 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.4.1 By Type
    • 7.4.2 By Procedure Type
    • 7.4.3 By End User
    • 7.4.4 India
    • 7.4.5 Japan
    • 7.4.6 South Korea
    • 7.4.7 Australia
    • 7.4.8 South East Asia
    • 7.4.9 Rest Of Asia Pacific
  • 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.5.1 By Type
    • 7.5.2 By Procedure Type
    • 7.5.3 By End User
    • 7.5.4 Brazil
    • 7.5.5 Argentina
    • 7.5.6 Peru
    • 7.5.7 Chile
    • 7.5.8 South East Asia
    • 7.5.9 Rest of Latin America
  • 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.6.1 By Type
    • 7.6.2 By Procedure Type
    • 7.6.3 By End User
    • 7.6.4 Saudi Arabia
    • 7.6.5 UAE
    • 7.6.6 Israel
    • 7.6.7 South Africa
    • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

  • 8.1. Recent Developments
  • 8.2. Company Categorization
  • 8.3. Supply Chain & Channel Partners (based on availability)
  • 8.4. Market Share & Positioning Analysis (based on availability)
  • 8.5. Vendor Landscape (based on availability)
  • 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL CARDIAC VALVULOTOME INDUSTRY

  • 9.1. Top Companies Market Share Analysis
  • 9.2. Company Profiles
    • 9.2.1 LeMaitre Vascular Inc
    • 9.2.2 Invamed
    • 9.2.3 LimFlow Inc
    • 9.2.4 B. Braun Melsungen AG
    • 9.2.5 Teleflex Incorporated
    • 9.2.6 StarFish Medical
    • 9.2.7 Koven Technology Inc
    • 9.2.8 Becton
    • 9.2.9 Dickinson And Company (BD)
    • 9.2.10 Symmetry Surgical Inc
    • 9.2.11 Andramed GmbH
    • 9.2.12 OxSyBio Ltd